Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-12-437868
Filing Date
2012-10-26
Accepted
2012-10-26 17:17:41
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM S-3/A d415240ds3a.htm S-3/A 218333
2 CONSENT OF KPMG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d415240dex231.htm EX-23.1 1742
  Complete submission text file 0001193125-12-437868.txt   221015
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: S-3/A | Act: 33 | File No.: 333-184091 | Film No.: 121165151
SIC: 2834 Pharmaceutical Preparations